Home About Browse Search
Svenska


Bolind Bågenholm, Annika, 2009. Early immune responses to an adjuvant (AbISCO-100) tested in porcine peripheral blood mononuclear cell. First cycle, G2E. Uppsala: SLU, Dept. of Biomedical Sciences and Veterinary Public Health

[img]
Preview
PDF
761kB

Abstract

Immune stimulating complex (iscom) matrix is a formulation that is used as an
adjuvant within research. The capability of the iscom matrix to elicit an immune
response when not present together with an antigen has not been extensively
investigated. One way to evaluate the status of the immune system is to measure the
amount of cytokines that usually are produced by various cell types during an immune
response. The aim of the present study was to evaluate the early immune responses in
porcine peripheral blood mononuclear cells (PBMC) after stimulation in vitro with the
iscom matrix, AbISCO®-100. The immune response was evaluated by measuring the
mRNA expression for various cytokines, a chemokine receptor (CXCR4) and
regulator of G-protein signaling (RGS16) in porcine PBMC after stimulation with
AbISCO®-100 or other inducers like a lipopolysaccharide (LPS) and a CpG
oligodeoxynucleotide (ODN 2216) used as controls. Quantitative real-time PCR
analysis showed low increase (p ≤ 0.05) in mRNA expression of the pro-inflammatory
cytokine TNF-α after 6 hours of stimulation with AbISCO®-100. This result
indicates that AbISCO®-100 may have the capacity to evoke a cytokine response by
itself. In addition, low but detectable increases in expression of IL-10, CXCR4 and
RGS16 were observed in one of five pigs after stimulation with AbISCO®-100. In
comparison, mRNA for IL-1β, IL-6, IL-10 (p ≤ 0.001), IL-12p40 and TNF-α (p ≤
0.01) was induced after 6 hours exposure of the PBMC to LPS and for IFN-α (p ≤
0.01) after 6 h in the presence of ODN 2216. Proliferation and viability test
performed, demonstrated that AbISCO®-100 was not mitogenic and just had a small
lytic effect on the PBMC . Thus, the iscom matrix, AbISCO®-100, does not appear to
be toxic or induce any harmful early inflammatory responses in porcine PBMC. An
extended period of incubation and use of a lager number of pigs are needed to better
examine the effects of AbISCO®-100.

Main title:Early immune responses to an adjuvant (AbISCO-100) tested in porcine peripheral blood mononuclear cell
Authors:Bolind Bågenholm, Annika
Supervisor:Fossum, Caroline
Examiner:Lunden, Anna
Series:UNSPECIFIED
Volume/Sequential designation:UNSPECIFIED
Year of Publication:2009
Level and depth descriptor:First cycle, G2E
Student's programme affiliation:NK002 Biotechnology - Bachelor's Programme 180 HEC
Department:(VH) > Dept. of Biomedical Sciences and Veterinary Public Health
Keywords:Adjuvant, porcine PBMC, ISCOM, ISCOMATRIX, AbISCO-100
URN:NBN:urn:nbn:se:slu:epsilon-3-10
Permanent URL:
http://urn.kb.se/resolve?urn=urn:nbn:se:slu:epsilon-3-10
Subjects:Animal diseases
Animal physiology and biochemistry
Language:English
Deposited On:08 Jul 2009 04:52
Metadata Last Modified:29 Nov 2016 12:03

Repository Staff Only: item control page

Downloads

Downloads per year (since September 2012)

View more statistics

Downloads
Hits